Perceptions, motivations, and concerns about living organ donation among people living with HIV

ABSTRACT Recent changes to United States law now permit people living with HIV (PLWH) to donate organs to HIV-infected (HIV+) recipients under research protocols. PLWH may have unique motivations for and concerns about living donation and understanding them is critical to ensuring the integrity of this novel approach to organ transplantation. We conducted in-depth interviews with PLWH from an urban HIV clinic who had previously indicated their willingness to be a living donor. Interviews elicited information on their motivations, perceived benefits, and concerns regarding living donation. Codes were identified inductively and then organized into themes and subthemes. Two coders independently analyzed the interviews and reconciled differences in coding by consensus. Thematic saturation was reached after 20 interviews. Motivations for living donation among PLWH included an altruistic desire to help others as well as HIV-specific motivations including solidarity with potential recipients and a desire to overcome HIV-related stigma. Perceived benefits of living donation included gratification from saving or improving the recipient's life and conferring a sense of normalcy for the HIV+ donor. Concerns about donation included the possibility of a prolonged recovery period, organ failure, and transmission of another strain of the virus to the recipients. PLWH had unique motivations, perceived benefits, and concerns about living donation in addition to those previously identified in the general population. These unique factors should be addressed in research protocols, informed consent processes, and the education and training of independent living donor advocates so that these endeavors are ethically sound.

[1]  D. Segev,et al.  Knowledge, attitudes, and planned practice of HIV‐positive to HIV‐positive transplantation in US transplant centers , 2018, Clinical transplantation.

[2]  L. Kucirka,et al.  Risk of End‐Stage Renal Disease in HIV‐Positive Potential Live Kidney Donors , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  A. Elsharkawy,et al.  HIV-Positive-to-HIV-Positive Liver Transplantation. , 2016, The New England journal of medicine.

[4]  S. Yerly,et al.  HIV‐Positive‐to‐HIV‐Positive Liver Transplantation , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  D. Segev,et al.  Realizing HOPE: The Ethics of Organ Transplantation From HIV-Positive Donors , 2016, Annals of Internal Medicine.

[6]  H. Holdaas,et al.  Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. , 2016, The New England journal of medicine.

[7]  D. Segev,et al.  From Bench to Bill: How a Transplant Nuance Became 1 of Only 57 Laws Passed in 2013. , 2016, Annals of surgery.

[8]  F. Palella,et al.  Challenges and Clinical Decision‐Making in HIV‐to‐HIV Transplantation: Insights From the HIV Literature , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  Richard D Moore,et al.  End-stage renal disease among HIV-infected adults in North America. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Mendelson,et al.  HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years. , 2015, The New England journal of medicine.

[11]  V. Krishnamurthi Risk of End-Stage Renal Disease Following Live Kidney Donation: Muzaale AD, Massie AB, Wang M-C, et al (Johns Hopkins Univ School of Medicine, Baltimore, MD; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; et al) JAMA 311:579-586, 2014 § , 2014 .

[12]  F. Dekker,et al.  Long-term risks for kidney donors. , 2014, Kidney international.

[13]  Mei-Cheng Wang,et al.  Risk of end-stage renal disease following live kidney donation. , 2014, JAMA.

[14]  A. Mocroft,et al.  Advanced chronic kidney disease, end‐stage renal disease and renal death among HIV‐positive individuals in Europe , 2013, HIV medicine.

[15]  J. Craig,et al.  The motivations and experiences of living kidney donors: a thematic synthesis. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  M. Shlipak,et al.  Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  N. Leidy,et al.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[18]  Elizabeth Molsen,et al.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[19]  W. Weimar,et al.  Long-term consequences of kidney donation. , 2009, The New England journal of medicine.

[20]  Marc Walter,et al.  Motivation for Living-Donor Liver Transplantation from the Donor’s Perspective: An In-Depth Qualitative Research Study , 2004, Transplantation.

[21]  A. Forsberg,et al.  Becoming a living kidney donor , 2003, Transplantation.

[22]  D. Segev,et al.  Moving from the HIV Organ Policy Equity Act to HIV Organ Policy Equity in action: changing practice and challenging stigma , 2018, Current opinion in organ transplantation.